Insmed
INSM
$25.59
Share price
3.52%
Change (1 day)
26.87%
Change (1 year)
Categories
Insmed (INSM) - P/B ratio
P/B ratio as of May 2024 : -11.5
According to Insmed's latest financial reports the company has a price-to-book ratio of -11.5.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Insmed - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -13.4 | -143.4% |
| 2022-12-31 | 30.8 | 291.78% |
| 2021-12-31 | 7.86 | -36.09% |
| 2020-12-31 | 12.3 | 50.19% |
| 2019-12-31 | 8.18 | 68.05% |
| 2018-12-31 | 4.87 | -26.37% |
| 2017-12-31 | 6.61 | 24.81% |
| 2016-12-31 | 5.30 | 47.23% |
| 2015-12-31 | 3.60 | -13% |
| 2014-12-31 | 4.14 | -10.88% |
| 2013-12-31 | 4.64 | 166.39% |
| 2012-12-31 | 1.74 | 208.92% |
| 2011-12-31 | 0.5641 | 10.17% |
| 2010-12-31 | 0.5120 | -36.72% |
| 2009-12-31 | 0.8091 | -103.99% |
| 2008-12-31 | -20.3 | -331.38% |
| 2007-12-31 | 8.75 | 36.27% |
| 2006-12-31 | 6.42 | -48.39% |
| 2005-12-31 | 12.4 | -8.78% |
| 2004-12-31 | 13.6 | 213.74% |
| 2003-12-31 | 4.35 | 584.38% |
| 2002-12-31 | 0.6355 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 5.04 | -143.97% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | 3.59 | -131.35% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | 5.91 | -151.62% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | 14.4 | -225.69% | 🇺🇸 USA |
 Array Technologies ARRY | 3.10 | -127.04% | 🇺🇸 USA |